Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty

Completed

Conditions studied: Corneal Edema Secondary to Corneal Endothelial Dystrophy

In brief

The purpose of this study is to report the early clinical outcomes in patients undergoing Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) for corneal edema secondary to corneal endothelial cell dysfunction, and to correlate this clinical data with the latest generation of imaging modalities available for the anterior segment.

Key facts

Study ID

NCT00744796

Run by

University of Texas Southwestern Medical Center

People needed

21

Starts

2006-12-01

Expected to finish

2009-07-01

Last updated by the study team

2020-12-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients aged 18 and up, where any age over 89 will be recorded as 'greater than 89', who have reviewed and understood the study consent form will be invited to participate in this study.
• They will be recruited based on diagnosis of corneal edema secondary to endothelial cell dysfunction undergoing DSAEK either alone or in conjunction with phacoemulsification and intraocular lens implantation at the University of Texas Southwestern Medical Center at Dallas.

You may not qualify if…

• Patients younger than 18 years will not be considered for this trial.
• The study will include all patients (no exclusion criteria) who have undergone and will undergo DSAEK implantation for corneal edema secondary to corneal endothelial dystrophy with an effort to determine its success.

Where it is running

• UT Southwestern Medical Center - Aston Ambulatory Clinic — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.